Investment
Features
FeesSafety
Academy
More
Pluang+

Autopilot liquidity tool shuts down as Aero launch integrates automation by April 2026

Protocol Fundamentals
30 Sep 2026
Crypto Briefing
View Source
Neutral
Autopilot liquidity tool shuts down as Aero launch integrates automation by April 2026

Autopilot, the automated liquidity management tool on Aerodrome powered by Mellow ALM, will cease public operations after March 25, 2026, with users required to withdraw deposits by April 25, 2026. This shutdown precedes the launch of Aero on October 21, 2026, which will unify Aerodrome and Velodrome under one token and include its own built-in automation, making third-party tools like Autopilot redundant. Users retain control of their assets via veNFTs during the transition, ensuring a non-custodial process. The gap between Autopilot's closure and Aero's launch means liquidity providers must find interim solutions for automated management.

Autopilot's planned shutdown ahead of Aero's launch comes as 17 of 50 major cryptocurrencies on Pluang rose while 32 fell. For readers following these digital assets, here is Pluang's market snapshot as of Oct 01, 2026 03:33 WIB: AAVE traded at Rp2.837.252 with a 1-day change of -4.72% and a typical hold time of 105 days, FIL at Rp18.473 with -4.64% and a typical hold time of 99 days, and AVAX at Rp195.564 with -4.63% and a typical hold time of 87 days. Pluang order activity showed mixed buy/sell ratios across these assets.

More News

Ademi LLP probes fairness of Capital's $728M all-stock deal with Peoples Bancorp.

Ademi LLP probes fairness of Capital's $728M all-stock deal with Peoples Bancorp.

Ademi LLP is investigating whether the $728.1 million all-stock acquisition of Capital by Peoples Bancorp offers fair value to Capital's public shareholders. The investigation focuses on the exchange ratio, benefits to company insiders, restrictions ...

Company Fundamentals
Neutral
4 hours ago
Foundayo lowers cardiovascular risks and deaths vs insulin glargine in type 2 diabetes patients, ACHIEVE-4 trial shows

Foundayo lowers cardiovascular risks and deaths vs insulin glargine in type 2 diabetes patients, ACHIEVE-4 trial shows

The Phase 3 ACHIEVE-4 trial found that Foundayo (orforglipron) reduced the risk of major cardiovascular events by 16% and cardiovascular death by 53% compared to insulin glargine in adults with type 2 diabetes and obesity. It also improved blood suga...

Company Fundamentals
Bullish
4 hours ago
Trinity Capital prices $350M 7.5% notes due 2032 to refinance debt and fund operations

Trinity Capital prices $350M 7.5% notes due 2032 to refinance debt and fund operations

Trinity Capital Inc. announced a $350 million public offering of 7.50% notes maturing in 2032. The unsecured notes will pay interest semiannually starting January 2027 and can be redeemed early at the company's option. Proceeds will be used to reduce...

Company Fundamentals
Neutral
4 hours ago
Fluence Energy faces class action over misleading production and revenue claims, stock plunges.

Fluence Energy faces class action over misleading production and revenue claims, stock plunges.

Fluence Energy, a renewable energy storage company, is sued in a class action for allegedly misleading investors about its ability to meet 2026 revenue and production targets. The lawsuit claims the company failed to disclose delays and operational i...

Market News
Bearish
4 hours ago
Royce Small-Cap Trust reports steady returns with a focus on small- and micro-cap stocks.

Royce Small-Cap Trust reports steady returns with a focus on small- and micro-cap stocks.

Royce Small-Cap Trust, a leading small-cap closed-end fund, reported a net asset value of $20.47 and a market price of $18.57 as of August 31, 2026. The fund aims for long-term capital growth by investing primarily in small- and micro-cap companies, ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App